Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|December 1, 2019
Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of Over 500 CavitiesSiyu Shi, Navjot Sandhu, Michael C Jin, et al.American Journal of Clinical Oncology|October 20, 2021
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life OutcomesElham Rahimy, Sara A Dudley, Rie von Eyben, et al.Neurosurgery|November 17, 2018
Long-Term Update of Stereotactic Radiosurgery for Benign Spinal TumorsAlexander L Chin, Dylann Fujimoto, Kiran A Kumar, et al.Seminars in Radiation Oncology|March 23, 2016
Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic RadiosurgerySusan M Hiniker, Leslie A Modlin, Clara Y Choi, et al.International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.JAMA Oncology|September 14, 2023
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled TrialMichael F Gensheimer, Harriet Gee, Hiroki Shirato, et al.Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyTimothy Gilligan, Daniel W Lin, Rahul Aggarwal, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.Pageof 5